ӳ��ý

Improving and accelerating drug development for nervous system disorders.

Pankevich DE, Altevogt BM, Dunlop J, Gage FH, Hyman SE. Improving and accelerating drug development for nervous system disorders. Neuron. 2014;84(3):546-53. doi:10.1016/j.neuron.2014.10.007

Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.

Karaca E, Harel T, Pehlivan D, et al. Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease. Neuron. 2015;88(3):499-513. doi:10.1016/j.neuron.2015.09.048

Large Scale Genetic Research on Neuropsychiatric Disorders in African Populations is Needed.

Dalvie S, Koen N, Duncan L, et al. Large Scale Genetic Research on Neuropsychiatric Disorders in African Populations is Needed. EBioMedicine. 2015;2(10):1259-61. doi:10.1016/j.ebiom.2015.10.002

Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition.

Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387(10028):1672-85. doi:10.1016/S0140-6736(15)00390-6

The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression.

Hamilton BA, Smith DJ, Mueller KL, et al. The vibrator mutation causes neurodegeneration via reduced expression of PITP alpha: positional complementation cloning and extragenic suppression. Neuron. 1997;18(5):711-22.